Awakn Life Sciences Corp. (AWKNF)
Awakn Life Sciences Corp. operates in the Biotechnology industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.07, up 0.00% on the session, giving a market capitalisation of $2.7M. On trailing twelve-month figures it carries a trailing P/E of -0.28, a net margin of -611.4%. Its beta of 2.60 implies it has historically moved more than the broad market.
Awakn Life Sciences Corp., a biotechnology firm, focuses on pioneering, advancing, implementing, and distributing psychedelic therapies to combat addiction and various other mental health conditions. Operating across the United Kingdom and Europe, the company maintains its corporate headquarters in Toronto, Canada.
Awakn Life Sciences Corp. is most often compared with the following Healthcare names: